腺瘤样息肉抗体

腺瘤样息肉抗体

〖别名〗Adenomatous Polyposis Coli; Adenomatous polyposis coli protein; APC; APC_HUMAN; CC1; Deleted in polyposis 2.5; DP2; DP2.5; DP3; FAP; FPC; GS; Protein APC. 

〖浓度〗1mg/1ml 

〖规格〗腺瘤样息肉抗体0.1ml/100μg  0.2ml/200μg   

〖抗体来源〗Rabbit  

〖克隆类型〗polyclonal 

〖交叉反应〗Human, Mouse, Rat, Pig, Cow, Horse, Rabbit,   

〖产品类型〗一抗    

〖研究领域〗肿瘤 心血管 细胞生物 免疫学 发育生物学 染色质和核信号 神经生物学 信号转导 干细胞 细胞周期蛋白 转录调节因子 肿瘤细胞生物标志物 表观遗传学  

〖蛋白分子量〗predicted molecular weight: 312kDa 

〖性状〗Lyophilized or Liquid 

〖免疫原〗KLH conjugated synthetic peptide derived from human APC 

〖亚型〗IgG 

〖纯化方法〗affinity purified by Protein A 

〖储存液〗0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide 

〖产品应用〗ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  IF=1:100-500 

（石蜡切片需做抗原修复） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

〖保存条件〗Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

〖产品介绍〗This gene encodes a tumor suppressor protein that acts as an antagonist of the Wnt signaling pathway. It is also involved in other processes including cell migration and adhesion, transcriptional activation, and apoptosis. Defects in this gene cause familial adenomatous polyposis (FAP), an autosomal dominant pre-malignant disease that usually progresses to malignancy. Disease-associated mutations tend to be clustered in a small region designated the mutation cluster region (MCR) and result in a truncated protein product. [provided by RefSeq].

Function : Tumor suppressor. Promotes rapid degradation of CTNNB1 and participates in Wnt signaling as a negative regulator. APC activity is correlated with its phosphorylation state. Activates the GEF activity of SPATA13 and ARHGEF4. Plays a role in hepatocyte growth factor (HGF)-induced cell migration. Required for MMP9 up-regulation via the JNK signaling pathway in colorectal tumor cells. Acts as a mediator of ERBB2-dependent stabilization of microtubules at the cell cortex. It is required for the localization of MACF1 to the cell membrane and this localization of MACF1 is critical for its function in microtubule stabilization.

Subunit : Forms homooligomers and heterooligomers with APC2. Interacts with DIAPH1 and DIAPH2. Interacts withPDZ domains of DLG1 and DLG3. Associates with catenins. Binds axin. Interacts with ARHGEF4 (via N-terminus). Interacts with MAPRE1 (viaC-terminus); probably required for APC targeting to the growingmicrotubule plus ends. Interacts with MAPRE2 and MAPRE3 (viaC-terminus). Found in a complex consisting of ARHGEF4, APC andCTNNB1. Interacts with SCRIB; may mediate APC targeting to adherensjunctions of epithelial cells. Interacts with SPATA13 (viaN-terminus and SH3 domain). Interacts with ASAP1 (via SH3 domain). Found in a complex composed of MACF1, APC, AXIN1, CTNNB1 and GSK3B. Interacts at the cell membrane with FAM123A and FAM123B (via ARM repeats).

Subcellular Location : Cell junction, adherens junction. Cytoplasm, cytoskeleton. Cell projection, lamellipodium. Cell projection, ruffle membrane. Cytoplasm. Cell membrane. Note=Associated with the microtubule network at the growing distal tip of microtubules. Accumulates in the lamellipodium and ruffle membrane in response to hepatocyte growth factor (HGF) treatment. The MEMO1-RHOA-DIAPH1 signaling pathway controls localization of the phosophorylated form to the cell membrane.

Tissue Specificity : Expressed in a variety of tissues.

Post-translational modifications : Phosphorylated by GSK3B. 

Ubiquitinated, leading to its degradation by the proteasome. Ubiquitination is facilitated by Axin. Deubiquitinated by ZRANB1/TRABID.

DISEASE : Familial adenomatous polyposis (FAP) [MIM:175100]: A cancer predisposition syndrome characterized by adenomatous polyps of the colon and rectum, but also of upper gastrointestinal tract (ampullary, duodenal and gastric adenomas). This is a viciously premalignant disease with one or more polyps progressing through dysplasia to malignancy in untreated gene carriers with a median age at diagnosis of 40 years. Note=The disease is caused by mutations affecting the gene represented in this entry.

Hereditary desmoid disease (HDD) [MIM:135290]: Autosomal dominant trait with 100% penetrance and possible variable expression among affected relatives. HDD patients show multifocal fibromatosis of the paraspinal muscles, breast, occiput, arms, lower ribs, abdominal wall, and mesentery. Desmoid tumors appears also as a complication of familial adenomatous polyposis. Note=The disease is caused by mutations affecting the gene represented in this entry.

Medulloblastoma (MDB) [MIM:155255]: Malignant, invasive embryonal tumor of the cerebellum with a preferential manifestation in children. Note=The gene represented in this entry may be involved in disease pathogenesis.

Mismatch repair cancer syndrome (MMRCS) [MIM:276300]: Autosomal dominant disorder characterized by malignant tumors of the brain associated with multiple colorectal adenomas. Skin features include sebaceous cysts, hyperpigmented and cafe au lait spots. Note=The disease is caused by mutations affecting the gene represented in this entry.

Gastric cancer (GASC) [MIM:613659]: A malignant disease which starts in the stomach, can spread to the esophagus or the small intestine, and can extend through the stomach wall to nearby lymph nodes and organs. It also can metastasize to other parts of the body. The term gastric cancer or gastric carcinoma refers to adenocarcinoma of the stomach that accounts for most of all gastric malignant tumors. Two main histologic types are recognized, diffuse type and intestinal type carcinomas. Diffuse tumors are poorly differentiated infiltrating lesions, resulting in thickening of the stomach. In contrast, intestinal tumors are usually exophytic, often ulcerating, and associated with intestinal metaplasia of the stomach, most often observed in sporadic disease. Note=The gene represented in this entry may be involved in disease pathogenesis.

Hepatocellular carcinoma (HCC) [MIM:114550]: A primary malignant neoplasm of epithelial liver cells. The major risk factors for HCC are chronic hepatitis B virus (HBV) infection, chronic hepatitis C virus (HCV) infection, prolonged dietary aflatoxin exposure, alcoholic cirrhosis, and cirrhosis due to other causes. Note=The gene represented in this entry may be involved in disease pathogenesis.

Similarity : Belongs to the adenomatous polyposis coli (APC) family.

Contains 7 ARM repeats.

Database links : UniProtKB/Swiss-Prot: P25054.2

本公司产品现货供应,货期短，质量可靠。仅用于科研实验不应用于临床。我们用专业的态度，一流的服务，全程实验指导，让你的数据不在成为实验奇谈。选择优质的腺瘤样息肉抗体，你的小伙伴都会惊呆的。本公司专业供应各种进口、国产一抗及二抗。代理品牌有R&D、Santa Cruz、Bipec、Millipore等国际知名品牌，品种多达7000多种。让你的科研之路不再布满荆棘。

我们还可以为客户提供产品说明书。腺瘤样息肉抗体拥有高纯度、高效价、高特异性的特点，可以应用于多种实验。免费送货上门，为您大大节省了时间和金钱。

Ab-(001)-06267 Anti-MMP-26/FITC 荧光素标记基质金属蛋白酶-26抗体IgG ，英文名： Anti-MMP-26/FITC ，规格： 0.2ml

Ab-(001)-06268 Anti-Moesin/FITC 荧光素标记膜突蛋白抗体IgG ，英文名： Anti-Moesin/FITC ，规格： 0.2ml

Ab-(001)-06269 Anti-MOG /FITC 荧光素标记髓鞘少树突胶质细胞糖蛋白抗体IgG ，英文名： Anti-MOG ，规格： 0.2ml

Ab-(001)-06270 Anti-HSA/FITC 荧光素标记鼠抗人血清白蛋白抗体IgG ，英文名： Anti-HSA/FITC ，规格： 0.2ml

Ab-(001)-06271 Anti-HAS/FITC 荧光素标记兔抗人血清白蛋白抗体IgG ，英文名： Anti-HAS/FITC ，规格： 0.2ml

Ab-(001)-06272 Anti-HSA/HRP 辣根过氧化物酶标记鼠抗人血清白蛋白单克隆抗体IgG ，英文名： Anti-HSA/HRP ，规格： 0.2ml

Ab-(001)-06273 Mouse Anti-YERSINIA PESTIS Monoclonal Anti-body /FITC 荧光素标记鼠抗鼠疫F1蛋白/鼠疫耶尔森氏菌荚膜抗原F1单克隆抗体IgG ，英文名： Mouse ，规格： 0.2ml

Ab-(001)-06274 Anti-Mouse IgA/FITC 荧光素标记兔抗小鼠IgA抗体 ，英文名： Anti-Mouse ，规格： 0.2ml

Ab-(001)-06275 Anti-MPO /FITC 荧光素标记髓过氧化物酶抗体IgG ，英文名： Anti-MPO ，规格： 0.2ml

Ab-(001)-06276 Anti-HAVCR1/KIM1/TIM1/FITC 荧光素标记甲型肝炎病毒细胞受体1IgG ，英文名： Anti-HAVCR1/KIM1/TIM1/FITC ，规格： 0.2ml

Ab-(001)-06277 Anti-HSD11B2/HSD2 /FITC 荧光素标记羟基类固醇脱氢酶11β2抗体IgG ，英文名： Anti-HSD11B2/HSD2 ，规格： 0.2ml

Ab-(001)-06278 Anti-MR/FITC 荧光素标记盐皮质激素受体抗体IgG ，英文名： Anti-MR/FITC ，规格： 0.2ml

Ab-(001)-06279 Anti-MRAS/Mras/FITC 荧光素标记原癌基因M-ras抗体IgG ，英文名： Anti-MRAS/Mras/FITC ，规格： 0.2ml

Ab-(001)-06280 Anti-Mre11/HNGS1/FITC 荧光素标记DNA损伤关键蛋白Mre11抗体IgG ，英文名： Anti-Mre11/HNGS1/FITC ，规格： 0.2ml

Ab-(001)-06281 Anti-Phospho-Mre11 (Ser676)/FITC 荧光素标记磷酸化DNA损伤关键蛋白Mre11抗体IgG ，英文名： Anti-Phospho-Mre11 ，规格： 0.2ml

Ab-(001)-06282 Anti-MRP1/FITC 荧光素标记多药耐药相关蛋白1抗体IgG ，英文名： Anti-MRP1/FITC ，规格： 0.2ml

Ab-(001)-06283 Anti-CITED1/ABCC1/FITC 荧光素标记结合转化激活因子CITED1抗体IgG ，英文名： Anti-CITED1/ABCC1/FITC ，规格： 0.2ml

Ab-(001)-06284 Anti-MRP2/FITC 荧光素标记多药耐药相关蛋白2抗体 ，英文名： Anti-MRP2/FITC ，规格： 0.2ml

Ab-(001)-06285 Anti-MRP3/FITC 荧光素标记多药耐药相关蛋白3抗体IgG ，英文名： Anti-MRP3/FITC ，规格： 0.2ml

Ab-(001)-06286 Anti-MRP4/ABCC4 /FITC 荧光素标记多药耐药相关蛋白4抗体IgG ，英文名： Anti-MRP4/ABCC4 ，规格： 0.2ml

Ab-(001)-06287 Anti-MRP5/ABCC5/FITC 荧光素标记多药耐药相关蛋白5抗体IgG ，英文名： Anti-MRP5/ABCC5/FITC ，规格： 0.2ml

Ab-(001)-06288 Anti-MrpL28 /FITC 荧光素标记线粒体核糖体蛋白L28抗体IgG ，英文名： Anti-MrpL28 ，规格： 0.2ml

Ab-(001)-06289 Anti-MSH-2/FITC 荧光素标记错配修复蛋白2抗体IgG ，英文名： Anti-MSH-2/FITC ，规格： 0.2ml

Ab-(001)-06290 Anti-MSK1/FITC 荧光素标记有丝分裂原和应激活化型蛋白激酶1抗体IgG ，英文名： Anti-MSK1/FITC ，规格： 0.2ml

Ab-(001)-06291 Anti-Phospho-MSK1 (Ser360)/FITC 荧光素标记磷酸化有丝分裂原和应激活化型蛋白激酶1抗体IgG ，英文名： Anti-Phospho-MSK1 ，规格： 0.2ml

Ab-(001)-06292 Anti-Phospho-MSK1 (Ser212)/FITC 荧光素标记磷酸化有丝分裂原和应激活化型蛋白激酶1抗体IgG ，英文名： Anti-Phospho-MSK1 ，规格： 0.2ml

Ab-(001)-06293 Anti-Phospho-MSK1 (Ser376) /FITC 荧光素标记磷酸化有丝分裂原和应激活化型蛋白激酶1抗体IgG ，英文名： Anti-Phospho-MSK1 ，腺瘤样息肉抗体规格： 0.2ml

Ab-(001)-06294 Anti-Phospho-MSK1 (Thr581) /FITC 荧光素标记磷酸化有丝分裂原和应激活化型蛋白激酶1抗体IgG ，英文名： Anti-Phospho-MSK1 ，规格： 0.2ml

Ab-(001)-06295 Anti-MSLN /FITC 荧光素标记间皮素抗体IgG ，英文名： Anti-MSLN ，规格： 0.2ml